Guardant Health (GH) PT Raised to $60 at Barclays
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Nasdaq futures slip on chip weakness; S&P 500 holds gains
- Massive market rotation raises question: Is the sell-AI trade here to stay?
- Goldman sees major AI and data center policy implications from ‘blue tsunami’
- Nvidia chips stockpile in Hong Kong awaits China import approval - report
- Goldman says this FX trade is the best hedge for the AI drawdown
Tweet
Share
E-mailGet Alerts GH Hot Sheet
Price: $168.58 --0%
Rating Summary:
30 Buy, 1 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 20 | Down: 36 | New: 6
Rating Summary:
30 Buy, 1 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 20 | Down: 36 | New: 6
Join SI Premium – FREE
Barclays analyst Luke Sergott raised the price target on Guardant Health (NASDAQ: GH) to $60.00 (from $55.00) while maintaining a Overweight rating.
You May Also Be Interested In
- TwinStrand Biosciences Announces USPTO Confirmation of Patentability of Core Duplex Sequencing Patent
- MercadoLibre (MELI) PT Lowered to $2,258 at StoneX
- Freedom Broker Downgrades McDonald's (MCD) to Hold
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
